Hematopoiesis and cytokines. Relevance to cancer and aging.
暂无分享,去创建一个
G. Rothstein | C. A. Baraldi-Junkins | A. Beck | Carole A. Baraldi-Junkins | Anna C. Beck | Gerald Rothstein
[1] H. Wieland,et al. Proliferation of human non-small-cell lung cancer cell lines: role of interleukin-6. , 1998, American journal of respiratory cell and molecular biology.
[2] I. Rensink,et al. Chimaeric anti‐interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose‐escalating study , 1998, British journal of haematology.
[3] C. Sawyers,et al. Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway. , 1998, Blood.
[4] M Ghiani,et al. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. , 1998, Seminars in oncology.
[5] G. Pawelec,et al. Human T‐cell clones in long‐term culture as a model of immunosenescence , 1997, Immunological reviews.
[6] D. Frasca,et al. Genes, immunity, and senescence: looking for a link , 1997, Immunological reviews.
[7] L. Tsui,et al. From naive to effector ‐ alterations with aging , 1997, Immunological reviews.
[8] H. Cohen,et al. Cancer and the functional status of the elderly , 1997, Cancer.
[9] D. Ernst,et al. T cell differentiation and cytokine expression in late life. , 1997, Developmental and comparative immunology.
[10] K. Anderson,et al. Interleukin-6 Overcomes p21WAF1 Upregulation and G1 Growth Arrest Induced by Dexamethasone and Interferon-γ in Multiple Myeloma Cells , 1997 .
[11] H J Cohen,et al. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.
[12] D. Frasca,et al. Regulation of cytokine production in aging: use of recombinant cytokines to upregulate mitogen-stimulated spleen cells , 1997, Mechanisms of Ageing and Development.
[13] M. Urashima,et al. Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. , 1997, Blood.
[14] M. Pahlavani,et al. The effect of age on the expression of Interleukin-2 , 1996, Mechanisms of Ageing and Development.
[15] Richard A. Miller. The Aging Immune System: Primer and Prospectus , 1996, Science.
[16] P. Szabo,et al. Treatment of old mice with IL-2 corrects dysregulated IL-2 and IL-4 production. , 1996, International immunology.
[17] G. Chatta,et al. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. , 1996, Blood.
[18] R. Daynes,et al. Dysregulation of IL-10 production with aging: Possible linkage to the age-associated decline in DHEA and its sulfated derivative , 1996, Experimental Gerontology.
[19] J. Buchanan,et al. Impaired expression of hematopoietic growth factors: A candidate mechanism for the hematopoietic defect of aging , 1996, Experimental Gerontology.
[20] N. Rosenthal,et al. Immune dysregulation in the aging human lung. , 1996, American journal of respiratory and critical care medicine.
[21] C. Caruso,et al. Cytokine production pathway in the elderly , 1996, Immunologic research.
[22] D. Ernst,et al. Aging and lymphokine gene expression by T cell subsets. , 2009, Nutrition reviews.
[23] J. Born,et al. Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep , 1995, Mechanisms of Ageing and Development.
[24] M. Pahlavani,et al. The age-related decline in the induction of IL-2 transcription is correlated to changes in the transcription factor NFAT. , 1995, Cellular immunology.
[25] T. Hosokawa,et al. Age-related enhancement of tumor necrosis factor (TNF) production in mice , 1995, Mechanisms of Ageing and Development.
[26] K. Yoneda,et al. Influence of aging and chemoradiotherapy on leucocyte function in oral cancer patients. , 1995, European journal of cancer. Part B, Oral oncology.
[27] D. Ernst,et al. Interleukin-10 production by splenic CD4+ cells and cell subsets from young and old mice. , 1994, Cellular immunology.
[28] R. Miller,et al. Age-associated decline in IL-4 production by murine T lymphocytes in extended culture. , 1993, Cellular immunology.
[29] G. Chatta,et al. Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF, GM-CSF, and IL-3. , 1993, Journal of gerontology.
[30] R. Klopp,et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. , 1993, Lymphokine and cytokine research.
[31] A. Kruse,et al. Investigations of the lymphokine system in elderly individuals , 1993, Mechanisms of Ageing and Development.
[32] D. Noonan,et al. The age-associated increase in IFN-gamma synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. , 1993, Journal of immunology.
[33] R. Daynes,et al. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. , 1993, Journal of immunology.
[34] B. Torbett,et al. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. , 1993, Journal of immunology.
[35] D. Ernst,et al. Aging and lymphokine production by t cell subsets , 1993, Stem cells.
[36] R. Daynes,et al. Natural Regulators of T-Cell Lymphokine Production In Vivo , 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.
[37] W. Ershler,et al. In vivo and in vitro characteristics of interleukin 6-transfected B16 melanoma cells. , 1992, Cancer research.
[38] R. Geha,et al. IgE regulation and lymphokine patterns in aging humans. , 1992, The Journal of allergy and clinical immunology.
[39] H. Broxmeyer,et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .
[40] G. Passeri,et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. , 1992, The Journal of clinical investigation.
[41] L. Balducci,et al. Recombinant Hemopoietic Growth Factors: Comparative Hemopoietic Response in Younger and Older Subjects , 1992, Journal of the American Geriatrics Society.
[42] M. Kluger,et al. Fever, tumor necrosis factor, and interleukin-6 in young, mature, and aged Fischer 344 rats. , 1992, The American journal of physiology.
[43] Haimin Xu,et al. Increase of plasma IL-6 concentration with age in healthy subjects. , 1992, Life sciences.
[44] R. Effros,et al. Influence of age and caloric restriction on macrophage IL-6 and TNF production. , 1991, Lymphokine and cytokine research.
[45] B. Torbett,et al. Cell proliferation and cytokine production by CD4+ cells from old mice , 1991, Journal of cellular biochemistry.
[46] C. Caruso,et al. Soluble interleukin-2 receptor release defect in vitro in elderly subjects , 1991, Mechanisms of Ageing and Development.
[47] I. Sanz,et al. Comparison of D, JH, and junctional diversity in the fetal, adult, and aged B cell repertoires. , 1991, Journal of immunology.
[48] A. Dräger,et al. Age‐related changes in lymphokine production related to a decreased number of CD45RBhi CD4+ T cells , 1991, European journal of immunology.
[49] D. Noonan,et al. Interleukin-6 production by murine B cells and B cell lines. , 1991, Cellular immunology.
[50] A. Richardson,et al. The expression of granulocyte/macrophage colony-stimulating factor in activated mouse lymphocytes declines with age. , 1990, Cellular immunology.
[51] B. Torbett,et al. Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. , 1990, Journal of immunology.
[52] T. Schnitzer,et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. , 1990, The American journal of medicine.
[53] H. Gisslinger,et al. Erythropoietin treatment of anemia associated with multiple myeloma. , 1990, The New England journal of medicine.
[54] M. Kubo,et al. Polymorphism of age‐related changes in interleukin (IL) production: differential changes of T helper subpopulations, synthesizing IL 2, IL3 and IL4 , 1990, European journal of immunology.
[55] C. Vissinga,et al. Impairment of CD3-dependent and CD3-independent activation pathways in CD4+ and in CD8+ T cells from old CBA/RIJ mice , 1990, Mechanisms of Ageing and Development.
[56] W. Boersma,et al. A decreased functional capacity of CD4+ T cells underlies the impaired DTH reactivity in old mice , 1990, Mechanisms of Ageing and Development.
[57] L. Pfeffer,et al. Defective expression of high affinity IL-2 receptors on activated T cells from aged humans. , 1990, International immunology.
[58] S. Rosenberg,et al. Antitumor activity of recombinant interleukin 6 in mice , 1990, The Journal of experimental medicine.
[59] M. Jourdan,et al. Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. , 1989, The Journal of clinical investigation.
[60] N. Holbrook,et al. Interleukin 2, interleukin 2 receptor, and interferon-gamma synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. , 1989, Clinical immunology and immunopathology.
[61] Richard A. Miller,et al. Pgp‐1hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A , 1989, European journal of immunology.
[62] D. Ernst,et al. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules. , 1989, Journal of immunology.
[63] D. Powers,et al. Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes. , 1989, Clinical and experimental immunology.
[64] M. Jourdan,et al. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. , 1989, Blood.
[65] K. Hirokawa,et al. Decline in the production of interleukin-3 with age in mice. , 1988, Cellular immunology.
[66] Rajiv K. Saxena,et al. Lectin-induced cytotoxic activity in spleen cells from young and old mice. Age-related changes in types of effector cells, lymphokine production and response. , 1988, Immunology.
[67] M. Thoman,et al. Partial restoration of Con A-induced proliferation, IL-2 receptor expression, and IL-2 synthesis in aged murine lymphocytes by phorbol myristate acetate and ionomycin. , 1988, Cellular immunology.
[68] D. Frasca,et al. Heterogeneity of immune responsiveness in healthy elderly subjects. , 1988, Clinical immunology and immunopathology.
[69] N. Holbrook,et al. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. , 1988, The Journal of clinical investigation.
[70] R. Christensen,et al. Kinetic evaluation of the pool sizes and proliferative response of neutrophils in bacterially challenged aging mice. , 1987, Blood.
[71] H. Brownstein,et al. Prevalence of Anemia and Correlation of Hemoglobin with Age in a Geriatric Screening Clinic Population , 1987, Journal of the American Geriatrics Society.
[72] Toshio Tanaka,et al. Age-associated changes in proliferative and differentiative response of human B cells and production of T cell-derived factors regulating B cell functions , 1987, Mechanisms of Ageing and Development.
[73] Toshio Tanaka,et al. Mechanisms of age-related decline in antigen-specific T cell proliferative response: IL-2 receptor expression and recombinant IL-2 induced proliferative response of purified tac-positive T cells , 1986, Mechanisms of Ageing and Development.
[74] Williams Lh,et al. Evaluation of the effect of age on hematopoiesis in the C57BL/6 mouse. , 1986 .
[75] D. Frasca,et al. Reconstitution of T cell functions in aging mice by thymosin α1 , 1986 .
[76] M. Pahlavani,et al. The effect of aging on the expression of interleukin 2 messenger ribonucleic acid. , 1986, Cellular immunology.
[77] D. Boggs,et al. Hematopoiesis and aging III: Anemia and a blunted erythropoietic response to hemorrhage in aged mice , 1985, American journal of hematology.
[78] H. Müller-Hermelink,et al. Admission criteria for immunogerontological studies in man: The senieur protocol , 1984, Mechanisms of Ageing and Development.
[79] P. Dallman,et al. Prevalence and causes of anemia in the United States, 1976 to 1980. , 1984, The American journal of clinical nutrition.
[80] K. Udupa,et al. Effect of age on hematopoiesis in man. , 1984, Blood.
[81] J. Goodwin,et al. Iron Status and Anemia in the Elderly: New Findings and a Review of Previous Studies , 1983, Journal of the American Geriatrics Society.
[82] B. Strehler,et al. Role of T cells and adherent cells in age-related decline in murine interleukin 2 production. , 1982, Journal of immunology.
[83] D. Lipschitz,et al. The correctability of the nutritional, immune, and hematopoietic manifestations of protein calorie malnutrition in the elderly. , 1982, Journal of the American College of Nutrition.
[84] M. Thoman,et al. Lymphokines and aging: interleukin-2 production and activity in aged animals. , 1981, Journal of immunology.
[85] C. Thompson,et al. The anemia of senescence , 1981, American journal of hematology.
[86] Richard A. Miller,et al. Decline, in aging mice, of the anti‐2, 4, 6‐trinitrophenyl (TNP) cytotoxic T cell response attributable to loss of Lyt‐2−, interleukin 2‐producing helper cell function , 1981, European journal of immunology.
[87] Lange Cf. Immunology of aging. , 1978, Progress in clinical pathology.
[88] T. Makinodan,et al. Decline in the growth potential of spleen-colonizing bone marrow stem cells of long-lived aging mice , 1976, The Journal of experimental medicine.
[89] F. Caird,et al. Anaemia in the elderly. , 1973, The Quarterly journal of medicine.